Gan & Lee Pharmaceuticals. (SHA:603087)
56.70
+2.62 (4.84%)
Jun 18, 2026, 3:00 PM CST
SHA:603087 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:603087 stock has a consensus rating of "Strong Buy" and an average price target of ¥72.50. The average 1-year stock price forecast is 27.87% higher than the current stock price, while the lowest is ¥68.00 (+19.93%) and the highest is ¥77.00 (+35.80%).
Price Target: ¥72.50 (+27.87%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:603087 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 4 |
Financial Forecast
Revenue This Year
4.73B
from 4.05B
Increased by 16.64%
Revenue Next Year
5.53B
from 4.73B
Increased by 17.06%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.8B | ||
| Avg | 4.7B | ||
| Low | 4.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.8% | ||
| Avg | 16.6% | ||
| Low | 14.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |